Radius Health (RDUS) Misses Q4 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Radius Health, Inc. Fourth Quarter & Full Year 2021 Results
February 24, 2022 7:30 AM ESTQ4 2021 TYMLOS® net revenue of $65 million vs. $60 million in Q4 2020, up 9%This is a record quarter over 18 quarters since the launch in May 2017FY 2021 TYMLOS Net Revenue of $219 vs. $208 million in FY 2020, up 5%Net Loss reduced by ~36%: ($70) million FY 2021 vs ($109) million FY 2020Adjusted EBITDA (Non-GAAP) loss reduced by ~56%: ($24) million FY 2021 vs. ($54) million FY 2020FY 2022 financial objectives: $232 million TYMLOS Net RevenueIncorporate seasonality of Net Revenue: ~42% in 1H and ~58% in 2H 2022($5) to $5 million Net Loss$35 to $45 million Company Adjusted EBITDA (Non-GAAP) FY 2022 asset objectives:... More



